After pursuing post-graduate studies in General Medicine and research in biochemical neuropsychopharmacology at The Royal Post-Graduate Medical School Dr. Ungar was in practice as a General Physician at The Princess Grace Hospital. Jointly with Dr. Raymond Prudo, Dr. Ungar founded a start-up company, The Doctors Laboratory PLC, a general pathology laboratory, that introduced a new paradigm in service provision for clinicians and pharmaceutical organizations throughout the United Kingdom and abroad. During his tenure as Chairman and a Board Director, The Doctors Laboratory PLC grew very substantially and was sold to Sonic Healthcare in 2002. Currently he is a Director of a NASDAQ quoted biopharmaceutical company creating drugs for acute and chronic orphan inflammatory diseases by modulating one or both of the complement C5 and leukotriene pathways. Dr. Ungar qualified in medicine, with additional qualifications in medical biochemistry at the Royal Free Hospital, London and was admitted as a member to The Royal College of Physicians. Dr. Ungar is a Life Fellow of The Royal Society of Medicine and is a founder and former Vice-President of The Independent Doctors Federation.
Dr. Stuart Ungar